Literature DB >> 1991297

Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors.

G Scambia1, P B Panici, F Battaglia, G Ferrandina, G Almadori, G Paludetti, M Maurizi, S Mancuso.   

Abstract

The authors investigated the presence of epidermal growth factor (EGF-R), estrogen (ER), progesterone (PR), and androgen (AR) receptors in 42 laryngeal squamous cell carcinomas and 20 normal laryngeal mucosa specimens. EGF-R were expressed in all tumor specimens analyzed, with significantly higher levels in tumor samples compared with normal mucosa (P less than 0.05). The immunohistochemical study demonstrated the presence of EGF-R in basal and parabasal cells of normal mucosa and in most of the cancer cells. There was no correlation between EGF-R and tumor localization or T classification. On the other hand, the authors did find an interesting correlation between EGF-R levels and grading, EGF-R levels being significantly higher in G3 than in G1-G2 tumors. Moreover, the three patients whose tumors expressed the highest EGF-R levels had disease recur within 8 months. Among tumor specimens, 9.5%, 35.7%, and 9.5% expressed very low but detectable ER, PR, and AR levels, respectively. No statistically significant difference was found between the levels of steroid receptors in the tumor and normal mucosa specimens, and neither was there any correlation of ER, PR, and AR with the pathologic findings. The authors' results suggest that the EGF-R system may play a role in regulating the growth of laryngeal cancer. Additional studies should demonstrate whether, as in other tumor types, EGF-R expression may have prognostic significance in human laryngeal cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991297     DOI: 10.1002/1097-0142(19910301)67:5<1347::aid-cncr2820670513>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.

Authors:  Maria B Koenigs; Armida Lefranc-Torres; Juliana Bonilla-Velez; Krupal B Patel; D Neil Hayes; Krzysztof Glomski; Paul M Busse; Annie W Chan; John R Clark; Daniel G Deschler; Kevin S Emerick; Rebecca J Hammon; Lori J Wirth; Derrick T Lin; Edmund A Mroz; William C Faquin; James W Rocco
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

Review 2.  Biologic markers, cellular differentiation, and metastatic head and neck cancer.

Authors:  S P Schantz
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

3.  Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.

Authors:  Y Hayashi; N Ishii; C Obayashi; K Jinnai; K Hanioka; Y Imai; H Itoh
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Protein tyrosine (de-)phosphorylation in head and neck squamous cell carcinoma.

Authors:  H P Verschuur; G Rijksen; B A van Oirschot; G P Schipper-Kester; P J Slootweg; G E Staal; G J Hordijk
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

5.  Prognostic significance of epidermal growth factor receptor in squamous cell carcinoma of the maxillary sinus.

Authors:  M Miyaguchi; S Sakai; J Olofsson; H Kuwabara; H Sakamoto
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 6.  The nature of the head and neck cancer.

Authors:  A G Maran; J A Wilson; M N Gaze
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

7.  Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck.

Authors:  M Gapany; R A Faust; S Tawfic; A Davis; G L Adams; K Ahmed
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

8.  Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia.

Authors:  Nitin Nitin; Kelsey J Rosbach; Adel El-Naggar; Michelle Williams; Ann Gillenwater; Rebecca R Richards-Kortum
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

9.  Protein tyrosine kinase activity in laryngeal squamous cell carcinoma.

Authors:  H P Verschuur; G Rijksen; G P Schipper-Kester; P J Slootweg; G J Hordijk; G E Staal
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

10.  Expression of hormone receptors in oropharyngeal squamous cell carcinoma.

Authors:  Hesham Mohamed; Katri Aro; Lauri Jouhi; Antti Mäkitie; Satu Remes; Caj Haglund; Timo Atula; Jaana Hagström
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-26       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.